Predictive value of B-type natriuretic peptide (BNP) for adverse cardiac events in patients undergoing primary total knee arthroplasty (TKA)

被引:3
|
作者
Gong Long [1 ]
Chen Hao [2 ]
Geng Li [1 ]
Yu Yang [1 ]
Zhou Hongzhong [3 ]
Wang Zhenhu [1 ]
机构
[1] Chinese PLA, Hosp 252, Dept Orthoped, Baihua East Rd, Baoding 071000, Hebei, Peoples R China
[2] Men Tou Gou Dist Hosp, Dept Cardiol, Beijing 100000, Peoples R China
[3] Affiliated Hosp Dezhou City, Dept Orthoped, 1766 San Ba Middle Rd, Dezhou 253000, Shandong, Peoples R China
关键词
JOINT ARTHROPLASTY; TOTAL HIP; OUTCOMES; MORTALITY; COMPLICATIONS; RISK;
D O I
10.1016/j.jos.2016.08.003
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: B-type natriuretic peptide (BNP) is a well-known biomarker to predict cardiac events following orthopedic procedures. However, further information regarding BNP can be completed. The present study aims to determine which of preoperative, postoperative or the difference between them (DVPPB) can best predict adverse cardiac events following TICA procedure and detect possible risk factors of high level of BNP. Methods: Between Jan. 2012 and Jan. 2014. 1120 included patients in 3 institutions have a minimum of 2 years follow-up. All clinical characteristics related to TKA procedure were put in total joint arthroplasty registry system and analyzed finally. The cut-off value of BNP predicting patients at increased risks of cardiac events after WA was evaluated by the Receiver Operating Characteristic (ROC) curve analysis. Results: Our results reveal DVPPB in comparison to preoperative and postoperative BNP can best predict cardiac events following primary TICA, and the optimal cut-off value was 825.5 pg/m1 with the highest Youden index of 0.62. Cigarette smoking, ASA III/IV/V, prior history of cardiac events, general anesthesia, surgery time, and tourniquet time are risk factors for DVPPB > 825.5 pg/ml. Conclusions: DVPPB in comparison to preoperative and postoperative BNP can best predict cardiac events following primary TKA. Cigarette smoking, ASA III/IV/V, prior history of cardiac events, general anesthesia, surgery time, and tourniquet time are risk factors for DVPPB > 825.5 pg/ml. We hope these results could be helpful to optimize health care among patients undergoing primary TKA. (C) 2016 Published by Elsevier B.V. on behalf of The Japanese Orthopaedic Association.
引用
收藏
页码:826 / 830
页数:5
相关论文
共 50 条
  • [41] Potential predictive value of B-type natriuretic peptide in disease progression in dilated cardiomyopathy
    Prasad, K
    Baig, MK
    Fredericks, S
    Holt, DW
    Grace, AA
    McKenna, WJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 502A - 502A
  • [42] Preoperative B-type natriuretic peptide testing in patients undergoing noncardiac surgery
    Rumman, Rawan
    Venus, Kevin
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (39) : E1350 - E1350
  • [43] B-type natriuretic peptide levels in patients with pericardial effusion undergoing pericardiocentesis
    Lauri, Gianfranco
    Rossi, Chiara
    Rubino, Mara
    Cosentino, Nicola
    Milazzo, Valentina
    Marana, Ivana
    Cabiati, Angelo
    Moltrasio, Marco
    De Metrio, Monica
    Grazi, Marco
    Campodonico, Jeness
    Assanelli, Emilio
    Riggio, Daniela
    Sandri, Maria Teresa
    Bonomi, Alice
    Veglia, Fabrizio
    Marenzi, Giancarlo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 212 : 318 - 323
  • [44] B-TYPE NATRIURETIC PEPTIDE LEVELS IN PATIENTS WITH PERICARDIAL EFFUSION UNDERGOING PERICARDIOCENTESIS
    Cosentino, Nicola
    Lauri, Gianfranco
    Rossi, Chiara
    Rubino, Mara
    Milazzo, Valentina
    Marana, Ivana
    Moltrasio, Marco
    De Metrio, Monica
    Grazi, Marco
    Campodonico, Jeness
    Marenzi, Giancarlo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1663 - 1663
  • [45] Elevated B-type Natriuretic Peptide Levels in Patients Undergoing Coronary Stenting
    Krishna, Abhay
    Kapoor, Aditya
    Kumar, Sudeep
    Tewari, Satyendra
    Garg, Naveen
    Goel, Pravin
    JOURNAL OF INVASIVE CARDIOLOGY, 2011, 23 (06): : 240 - 245
  • [46] Cardiac troponin T (TnT) and B-Type natriuretic peptide. (BNP) which has the better prognostic ability for predicting cardiac events in hemodialysis (HD) patients?
    Yasuda, K
    Kasuga, H
    Kawade, Y
    Kitai, S
    Iwashima, S
    Yuzawa, Y
    Matsuo, S
    Toriyama, TB
    Kawahara, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 491A - 491A
  • [47] Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes
    Epshteyn, V
    Morrison, K
    Krishnaswamy, P
    Kazanegra, R
    Clopton, P
    Mudaliar, S
    Edelman, S
    Henry, R
    Maisel, A
    DIABETES CARE, 2003, 26 (07) : 2081 - 2087
  • [48] Is B-type natriuretic peptide (BNP) similarly associated with mortality in patients with and without heart failure?
    Fukushima, Norihide
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [49] Primary results of the BNP Multinational Study: B-type natriuretic peptide in the emergency diagnosis of heart failure
    Maisel, AS
    Kazanegra, R
    McCord, J
    Nowak, RM
    Hollander, JE
    Duc, P
    Steg, G
    Omland, T
    Westheim, A
    Abraham, WT
    Storrow, AB
    Lamba, S
    Wu, AH
    McCullough, PA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 201A - 201A
  • [50] Influence of the use of vasoactive amines on B-type natriuretic peptide levels measured in patients undergoing cardiac surgery
    Felipe, AR
    Gomes, RV
    Nogueira, PM
    Fernandes, MAD
    Rodrigues, G
    Aranha, FG
    Campos, LAD
    Dohmann, HFD
    CHEST, 2005, 128 (04) : 275S - 275S